Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer.

Abstract

Sevelamer arrested the progression of valvular and vascular calcification in almost 50% of hemodialysis subjects. Sevelamer treatment, plus intensive control of calcium and phosphorus levels, may attenuate progression of, or achieve regression in, cardiac valvular calcification.